These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28553295)

  • 61. Feasibility and Acceptability of an mHealth-Based Approach as an HIV Prevention Strategy Among People Who Use Drugs on Pre-Exposure Prophylaxis.
    Shrestha R; Altice FL; DiDomizio E; Sibilio B; Ranjit YS; Copenhaver MM
    Patient Prefer Adherence; 2020; 14():107-118. PubMed ID: 32021122
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The PrEP Care Continuum Among Cisgender Women Who Sell Sex and/or Use Drugs Globally: A Systematic Review.
    Glick JL; Russo R; Jivapong B; Rosman L; Pelaez D; Footer KHA; Sherman SG
    AIDS Behav; 2020 May; 24(5):1312-1333. PubMed ID: 31807973
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Review of Real-World Implementation Data on Emtricitabine-Tenofovir Disoproxil Fumarate as HIV Pre-exposure Prophylaxis in the United States.
    Adams JL; Shelley K; Nicol MR
    Pharmacotherapy; 2019 Apr; 39(4):486-500. PubMed ID: 30815960
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment.
    Shrestha R; Copenhaver M
    Front Public Health; 2018; 6():195. PubMed ID: 30062091
    [No Abstract]   [Full Text] [Related]  

  • 65. Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study.
    Shrestha R; Altice FL; Karki P; Copenhaver MM
    AIDS Behav; 2018 Aug; 22(8):2640-2649. PubMed ID: 29582199
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users.
    Shrestha R; Karki P; Altice FL; Dubov O; Fraenkel L; Huedo-Medina T; Copenhaver M
    AIDS Behav; 2018 Apr; 22(4):1228-1238. PubMed ID: 28695388
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of healthcare providers in the roll out of preexposure prophylaxis.
    Krakower DS; Mayer KH
    Curr Opin HIV AIDS; 2016 Jan; 11(1):41-8. PubMed ID: 26417953
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Developing an Integrated, Brief Biobehavioral HIV Prevention Intervention for High-Risk Drug Users in Treatment: The Process and Outcome of Formative Research.
    Shrestha R; Altice F; Karki P; Copenhaver M
    Front Immunol; 2017; 8():561. PubMed ID: 28553295
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study.
    Shrestha R; Altice FL; Sibilio B; Ssenyonjo J; Copenhaver MM
    Contemp Clin Trials; 2019 Jul; 82():77-84. PubMed ID: 31229618
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adapting an Evidence-Based HIV Prevention Intervention Targeting High-Risk Migrant Workers: The Process and Outcome of Formative Research.
    Shrestha R; Karki P; Pandey S; Copenhaver M
    Front Public Health; 2016; 4():61. PubMed ID: 27066474
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A Novel Capacity-Strengthening Intervention for Frontline Harm Reduction Workers to Support Pre-exposure Prophylaxis Awareness-Building and Promotion Among People Who Use Drugs: Formative Research and Intervention Development.
    Glick JL; Zhang L; Rosen JG; Yaroshevich K; Atiba B; Pelaez D; Park JN
    JMIR Form Res; 2023 Apr; 7():e42418. PubMed ID: 37052977
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adapting an Evidence-Based Intervention Targeting HIV-Infected Prisoners in Malaysia.
    Copenhaver MM; Tunku N; Ezeabogu I; Potrepka J; Zahari MM; Kamarulzaman A; Altice FL
    AIDS Res Treat; 2011; 2011():131045. PubMed ID: 21860786
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Adaptation of an evidence-based intervention targeting HIV-infected prisoners transitioning to the community: the process and outcome of formative research for the Positive Living Using Safety (PLUS) intervention.
    Copenhaver M; Chowdhury S; Altice FL
    AIDS Patient Care STDS; 2009 Apr; 23(4):277-87. PubMed ID: 19260773
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment.
    Shrestha R; Karki P; Altice FL; Huedo-Medina TB; Meyer JP; Madden L; Copenhaver M
    Drug Alcohol Depend; 2017 Apr; 173():107-116. PubMed ID: 28214391
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.